Literature DB >> 6035054

Heterokaryosis and alkaloid production in Claviceps purpurea.

A M Amici, T Scotti, C Spalla, L Tognoli.   

Abstract

Strain 275 FI of Claviceps purpurea, which produces large amounts of peptide alkaloids in submerged culture, is a heterokaryon; after several generations on agar media, it segregates the single components. These components (by us labeled V, C, and W) are stable and produce almost no alkaloids under described conditions of submerged culture. The mycelium of strain 275 FI consists of hyphae with multinucleate cells and does not produce conidia. Strains V, C, and W form numerous anastomoses when grown together on agar. By combining strains V and C, a heterokaryon similar to 275 FI in appearance has been obtained. This new strain produces amounts of alkaloids much larger than those produced by V and C separately or in associated submerged culture. We conclude, therefore, that in strain 275 FI the heterokaryotic condition is favorable to the production of alkaloids. Several conidiaproducing cultures of C. purpurea of various origins, as well as sclerotia of the same species, have been examined. The results demonstrated that the heterokaryotic condition is rare in the cultures, but it is frequent in the mycelium from sclerotia. Since it is known that the production of alkaloids is typical of the sclerotial phase in C. purpurea, it is suggested that this capacity is related to the heterokaryosis of the producing strains.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6035054      PMCID: PMC546985          DOI: 10.1128/am.15.3.611-615.1967

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  4 in total

1.  Morphological observations on different species of Claviceps Tul. grown in submerged culture.

Authors:  A TONOLO; L VERO-BARCELLONA
Journal:  Sci Rep Ist Super Sanita       Date:  1961-07

2.  Formation of an enzyme through complementary action of mutant alleles in separate nuclei in a heterocaryon.

Authors:  J R FINCHAM; J A PATEMAN
Journal:  Nature       Date:  1957-04-06       Impact factor: 49.962

3.  Ergotamine production in submerged culture and physiology of Calviceps purpurea.

Authors:  A M Amici; A Minghetti; T Scotti; C Spalla; L Tognoli
Journal:  Appl Microbiol       Date:  1967-05

4.  Production of ergotamine by a strain of Claviceps purpurea (Fr.) Tul.

Authors:  A M Amici; A Minghetti; T Scotti; C Spalla; L Tognoli
Journal:  Experientia       Date:  1966-06-15
  4 in total
  6 in total

1.  Ergot alkaloids. V. Homokaryosis of the sclerotia of Claviceps purpurea (Fr.) Tul.

Authors:  K Strnadová; J Kybal
Journal:  Folia Microbiol (Praha)       Date:  1974       Impact factor: 2.099

2.  Production of peptide ergot alkaloids in submerged culture by three isolates of Claviceps purpurea.

Authors:  A M Amici; A Minghetti; T Scotti; C Spalla; L Tognoli
Journal:  Appl Microbiol       Date:  1969-09

3.  A new method for isolation of saprophytic cultures of Claviceps fusiformis from sclerotia.

Authors:  J D Desai; A J Desai; H C Vaidya
Journal:  Folia Microbiol (Praha)       Date:  1982       Impact factor: 2.099

4.  Inactivation of the indole-diterpene biosynthetic gene cluster of Claviceps paspali by Agrobacterium-mediated gene replacement.

Authors:  László Kozák; Zoltán Szilágyi; Barbara Vágó; Annamária Kakuk; László Tóth; István Molnár; István Pócsi
Journal:  Appl Microbiol Biotechnol       Date:  2018-02-19       Impact factor: 4.813

5.  Genetics of the ergot fungus Claviceps purpurea : I. Proof of a monoecious life cycle and segregation patterns for mycelial morphology and alkaloid production.

Authors:  K Esser; P Tudzynski
Journal:  Theor Appl Genet       Date:  1978-07       Impact factor: 5.699

6.  Sympatric divergence of the ergot fungus, Claviceps purpurea, populations infecting agricultural and nonagricultural grasses in North America.

Authors:  Miao Liu; Parivash Shoukouhi; Kassandra R Bisson; Stephen A Wyka; Kirk D Broders; Jim G Menzies
Journal:  Ecol Evol       Date:  2020-12-12       Impact factor: 2.912

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.